Eco Animal Health (GB:EAH) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
ECO Animal Health Group PLC, a prominent player in the animal pharmaceuticals market, has announced that their CEO, David Hallas, has acquired 18,181 shares at 110 pence per share, thereby raising his total stake in the company to 0.16%. The company is known for its lead product Aivlosin®, which treats respiratory and intestinal diseases in pigs and poultry, and operates globally with over 200 employees.
For further insights into GB:EAH stock, check out TipRanks’ Stock Analysis page.